Abstract 16955: Effects of Evolocumab (AMG 145) as a Monotherapy or in Combination with Statins on Lipoprotein Particles and Subclasses

Ren Xu,Matt Peach,Michael Tracy,Lisa Hamilton,Stephen Djedjos,Ricardo Dent,Dan Fitzpatrick,Robert A. Scott,Scott M. Wasserman

Abstract 16955: Effects of Evolocumab (AMG 145) as a Monotherapy or in Combination with Statins on Lipoprotein Particles and Subclasses

2014

Ren Xu
Matt Peach
Michael Tracy
Lisa Hamilton
Stephen Djedjos
Ricardo Dent
Dan Fitzpatrick
Robert A. Scott
Scott M. Wasserman

Background: Evolocumab (AMG 145) reduces LDL-C alone or in combination with statins. We evaluated the effect of evolocumab on lipoprotein particles from subjects receiving evolocumab as monotherapy...

Keywords:

Clinical trial
Evolocumab
Lipoprotein
Cardiology
Oncology
Diabetes mellitus
Internal medicine
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations